A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2013
12/04/2013	CN102432620B Resveratrol tetramer compound, its preparation method and application
12/04/2013	CN102424818B Caspase-1-ES cell line induced by mifepristone
12/04/2013	CN102397414B Pure Chinese medicinal composition for treating gout in poultry and preparation method
12/04/2013	CN102302615B Effective site group of daphne giraldii nitsche leaf, preparation method, medicinal composition and application thereof
12/04/2013	CN102295643B 2-(pyridin-2-ylamino)-pyrido[2,3d]pyrimidin-7-ones
12/04/2013	CN102127114B Non-natural chiral amino acid derivative with di-organic phosphate group and synthesis method thereof
12/04/2013	CN101862326B Medicine compound containing febuxostat
12/04/2013	CN101622243B Sulfonamide derivative
12/03/2013	US8598324 Anti-pathogen treatments
12/03/2013	US8597700 Method of treating osteoporosis with extract of Dioscorea sp
12/03/2013	CA2651039C Hyaluronic acid binary mixtures and therapeutic use thereof
12/03/2013	CA2504270C Peptide fragments of the harp factor inhibiting angiogenesis
11/2013
11/28/2013	WO2013176469A1 Antibody able to suppress osteoclast differentiation
11/28/2013	WO2013176327A1 Pharmaceutical composition and health functional food for preventing or treating bone diseases, containing lactic acid bacteria fermentation product of detox soup of coptis chinensis as active ingredients
11/28/2013	WO2013176054A1 Agent containing ascorbic acid derivative, and use for said agent
11/28/2013	WO2013175500A1 Delazed release pharmaceutical compositions of salsalate
11/28/2013	WO2013175415A1 Substituted pyrimidine compounds and uses thereof
11/28/2013	WO2013175385A1 Bisphosphonates vinylic monomers and polymers and uses thereof
11/28/2013	WO2013175270A1 Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
11/28/2013	WO2013174863A1 Chondroitin for use in medicine
11/28/2013	WO2013174847A1 Low -molecular -weight biotechnological chondroitin 6 - sulphate for prevention of osteoarthritis
11/28/2013	WO2013174812A1 Fructus ligustri lucidi for bones in young subjects
11/28/2013	WO2013174810A1 Fructus ligustri lucidi for growth in children
11/28/2013	WO2013173971A1 Use of fructus ligustri lucidi in the manufacture of a medicament for the prevention or treatment of a condition linked to weak bones in a young subject
11/28/2013	US20130317013 Ep4 receptor agonist, compositions and methods thereof
11/28/2013	US20130316999 Substituted oxazolidinones and their use in the field of blood coagulation
11/28/2013	US20130316990 Use of vitamin d compounds
11/28/2013	US20130315893 Humanized anti-il-20 antibody and uses thereof
11/27/2013	EP2666777A1 Certain chemical entities having an imidazo<4,5-b>pyrazin-2(3H)-one core, compositions and methods
11/27/2013	CN203303500U Protective cover capable of treating rheumatoid gonitis and anconitis
11/27/2013	CN1899275B Use of composition of rheinic acid or rheinic acid compounds in preparing medicine for treating osteoarthritis
11/27/2013	CN103415513A Benzodioxane inhibitors of leukotriene production
11/27/2013	CN103415293A Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
11/27/2013	CN103408612A Phenanthrene and dihydrophenanthrene compounds and application thereof
11/27/2013	CN103408586A Phosphoric citrate and synthesis method thereof
11/27/2013	CN103408585A Method for synthesizing phosphoric citrate derivative
11/27/2013	CN103408533A Novel substituted pyridin-2-ones and pyridazin-3-ones
11/27/2013	CN103408501A Benzyl pyrimidine derivatives, and preparation method and medical application thereof
11/27/2013	CN103405757A Composition for health-care product, health-care product and using method thereof
11/27/2013	CN103405755A Pharmaceutical composition for treating primary osteoporosis
11/27/2013	CN103405740A Chinese medicine composition for external use and preparation method thereof
11/27/2013	CN103405737A Formula for treatment of osteomyelitis, bone tuberculosis and osteocarcinoma and preparation method
11/27/2013	CN103405733A Chinese medicine preparation for treating joint pain of middle aged and elderly people
11/27/2013	CN103405682A Traditional Chinese medicine for treating gout and preparation method thereof
11/27/2013	CN103405678A Traditional Chinese medicine for treating rheumatism
11/27/2013	CN103405661A Formula for treatment of diseases about fracture, bone fracture, calcium supplement and osteoporosis and preparation method
11/27/2013	CN103405653A External preparation for treating gouty arthritis
11/27/2013	CN103405644A Plaster for treating bone disease
11/27/2013	CN103405612A TCM composition for treatment of periarthritis of shoulder and preparation method thereof
11/27/2013	CN103405582A Traditional Chinese medicine composition for improving joint gall of rheumatoid arthritis
11/27/2013	CN103405573A Cancellous bone-invigorating formula for treating osteoporosis and preparation technology thereof
11/27/2013	CN103405568A Traditional Chinese medicine for treating lumbar disc herniation
11/27/2013	CN103405564A Traditional Chinese medicine for treatment of knee osteoarthritis
11/27/2013	CN103405551A Compound essential oil for preventing osteoporosis
11/27/2013	CN103405524A Cancellous bone-reinforcing formula for treating osteoporosis and preparation technology of same
11/27/2013	CN103405514A Antihypertensive pillow with medicine inside
11/27/2013	CN103405509A Cancellous bone-benefiting prescription for treating osteoporosis and preparation technology of
11/27/2013	CN103405494A Bauhinia championii n-butyl alcohol extract as well as preparation method and application thereof
11/27/2013	CN103405487A Chinese medicine compound effective part with effect of treating arthritis
11/27/2013	CN103405434A VEGFR-2 (Vascular Endothelial Growth Factor Receptor-2) inhibitor and application thereof
11/27/2013	CN103405433A Medicinal combination containing ilaprazole and naproxen
11/27/2013	CN103405432A Medicinal combination containing ilaprazole sodium and naproxen
11/27/2013	CN103405429A VEGFR-2 (Vascular Endothelial Growth Factor Receptor-2) inhibitors and use thereof
11/27/2013	CN103405426A Application of compound in preparation of medicines for treating acute gout
11/27/2013	CN103405404A Novel use of dimethyloxalglycine and mesenchymal stem cell separation method
11/27/2013	CN103405398A Allantoin preparation and application thereof
11/27/2013	CN102847162B Method for preparation of active immunoadsorbent carrier
11/27/2013	CN102824590B Preparation method of traditional Chinese medicine lotion for treating closed fracture with syndrome of breathing pain
11/27/2013	CN102824584B Method of preparing traditional Chinese medicine lotion for treating addicted-to-strong tea-type closed fracture
11/27/2013	CN102755392B Externally-used plaster for relieving pain caused by femoral head necrosis
11/27/2013	CN102743665B Chinese medicinal composition for promoting healing after boneblast, as well as preparation method and application thereof
11/27/2013	CN102626444B Medicine combination for treating gout and preparing method and application thereof
11/27/2013	CN102579978B External traditional Chinese medicine composition for treating scapulohumeral periarthritis
11/27/2013	CN102579518B Pterocephalus hookeri (C.B.Clarke) Hoeck total saponin extract and preparation method and application thereof
11/27/2013	CN102552705B Traditional Chinese medicinal capsule for treating lumbar disc herniation and femoral head necrosis
11/27/2013	CN102488765B Medicine for treating osseous rheumatism and cerebral apoplexy
11/27/2013	CN102429881B Method for preparing benzbromarone tablets
11/27/2013	CN102397324B Method for determining phenylpropanoid glycoside substances in Tibetmedicine Lamiophlomis rotata
11/27/2013	CN101918362B 吡啶衍生物 Pyridine derivatives
11/27/2013	CN101842385B Food material for inhibiting formation of osteoclast
11/27/2013	CN101744960B Sangusis draconis notoginseng bone-setting ointment and preparation method thereof
11/27/2013	CN101612399B PDGFR-alpha antagonists for treatment of metastatic bone cancer
11/27/2013	CN101530526B External Chinese medicament for treating hyperosteogeny and lumbar interveterbral disc protrusion
11/26/2013	US8592395 Therapeutic compounds
11/26/2013	CA2649736C Heterocyclic compounds as inhibitors of c-fms kinase
11/26/2013	CA2603518C Nutrient composition for promoting collagen production
11/26/2013	CA2567190C Combinations of hyaluronic acid and polyunsaturated fatty acids
11/21/2013	WO2013173330A1 Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions
11/21/2013	WO2013173158A1 Therapeutic uses of fibroblast growth factor 21 proteins
11/21/2013	WO2013172517A1 Bone loss preventing and bone regeneration or bone formation promoting pharmaceutical composition comprising muramyl dipeptide
11/21/2013	WO2013172379A1 Novel antibody and application thereof
11/21/2013	WO2013170971A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a nsar
11/21/2013	WO2013170694A1 Costunolide derivative, pharmaceutical composition thereof as well as preparation method and use thereof
11/21/2013	US20130310388 Modulators of TNF-Alpha Signaling
11/21/2013	US20130310320 Boronic ester and acid compounds, synthesis and uses
11/21/2013	US20130309325 Composition and method for promoting joint and bone health
11/21/2013	US20130309232 Vascular endothelial growth factor 2
11/20/2013	EP2664346A1 Anti-sclerostin antibodies
11/20/2013	EP2664340A2 A direct drug delivery system based on thermally responsive biopolymers
11/20/2013	EP2664336A2 Regimens for intra-articular viscosupplementation

1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 820